HTTP Batch 3 Session Topics

Module 1: Basic Knowledge on HIV Care

Session 1
Nov 7, 2019
Lecture 1: History & Epidemiology
Lecture 2: Clinical Course of HIV
Dr. Angelo Ramos
Dr. Karl Evans Henson
Session 2
Nov 14, 2019
Lecture 3: First Visit
Lecture 4: PhilHealth & OHAT
Dr. Kate Leyritana
Dr. Mary Ann Remonte
Session 3
Nov 21, 2019
Lecture 5: TB & HIV Dr. Christine Penalosa-Ramos
Session 4
Nov 28, 2019
Lecture 6: Common Opportunistic Infections Dr. Cybele Abad
Session 5
Dec 5, 2019
Lecture 7: ART Dosing & Side Effects Dr. Kate Leyritana
Session 6
Dec 12, 2019
Lecture 8: Follow-up of patients on treatment Dr. Joseph Buensalido

Session 7
Dec 19, 2019
Lecture 9: Adherence Ed Busi

Session 8
Jan 7, 2020
Lecture 10: Treatment Failure and ResistanceDr. Edsel Salvana

Module 2: Advanced Knowledge on HIV Care

Session 9
Jan 9, 2020
Lecture 11: Non-Infectious
Neurological Issues
Dr. Michelle Anlacan
Session 10
Jan 16, 2020
Lecture 12: Mental Health & Crisis Management, and Counseling Ivy Hapitan
Session 11
Jan 23, 2020
Lecture 13: Dermatology
Lecture 14: Nutrition & Wellness
Dr. Coco Tiongson
Sir Arvin Orajay
Session 12
Jan 30, 2020
Lecture 15: PEP, PrEP, SRR
Dr. Dessi Roman
Session 13
Feb 6, 2020
Lecture 16: Substance Abuse &
Harm Reduction
Lecture 17: Hepatitis and HIV
Rod Olete
Dr. Edhel Tripon
Session 14
Feb 13, 2020
Lecture 18: Prevention of Mother-
to-Child Transmission
Lecture 19: Pediatric HIV

Dr. Helen Madamba
Dr. Jing Pagcatipunan
Session 15
Feb 20, 2020
Lecture 20: SOGIESC
Lecture 21: Transhealth
Naomi Fontanos
Dr. Jojo Sescon
Session 16
Feb 27, 2020
Lecture 22:
HIV Stigma and Discrimination
Lecture 23: STI & Management
Dr. Louie Ocampo
Dr. Evalyn Roxas
Session 17
Mar 5, 2020
Lecture 24: RA 11166
Lecture 25: Self Care
Marcel Millam
Dr. Ronald Castillo
Supplemental Session 1COVID 101 Dr. Kate Leyritana
Supplemental Session 2Life in the Time of COVIDDr. Angelo Ramos
Continuity of CareBenj Baguingan
Supplemental Session 3 COVID-19 and
HIV, Sex and Intimacy
Dr. Louie Ocampo
Supplemental Session 4Mental Health Awareness
During a Pandemic
Dr. Gia Sison
Dr. RJ Naguit
Risk CommunicationProf. Buenalyn

How to Connect Guide


1. Go to and click on Join a Meeting in the top right of the screen


2. Enter the Meeting ID of the session.

3. Click Start from your browser.



  1. Click Join.

2. Enter meeting number.  Enter your name in the format of NAME (POSITION, INSTITUTION). Leave the 2 boxes unchecked so we can see and hear you.



• If you are using a desktop computer, you will need speakers and a microphone to join the meeting (for groups of two or more), or a headset (for individual participants).


• To turn on the webcam and microphone, please open Zoom and click on Settings (top right corner) and test your devices in the Audio/Video section.


• If you join the meeting before it starts, you will receive this notification.

• In the meantime, you can check the audio settings.


• If you are in the meeting and you need to fix our audio settings, look at the bottom left of your screen (for PC/laptop users)


• For problems encountered, participants may directly contact our coordinator at

Dos and Don’ts for Participants

Below are some tips on how to practice proper telehealth etiquette as a participant.

 Join the session on time
 Make sure your room is well lit and quiet
 Minimize distractions and interruptions by letting other people know you are in a videoconference
 Maintain a professional demeanor while on camera
 Place your mobile phone on silent mode
 Make eye contact with the camera, rather than the monitor, when speaking
 Mute your microphone when you are not speaking
 Use the chatroom to raise your hand, to ask a question or make a comment. Wait for the facilitator to call on you
 Use the chatroom to participate if you do not have a microphone
 Introduce yourself and your institution before you speak
 Bring questions
 Complete the session evaluation
 Participate!

X Position your camera too low or too high
X Do other work while participating in the session
X Join from a noisy place
X Talk while someone else is speaking
X Have unrelated conversations or talk on the phone during the session
X Criticize another participant or colleague
X Share your screen without permission

SHIP Featured in DW

Dying of Shame and AIDS in the Philippines

May 31, 2016|

Manila in 2016 is starting to look like San Francisco in the 1980s when the AIDS took the lives of mostly gay men. Image by Veejay Villafranca. Philippines, 2016.

The Facebook posts were becoming so common that it no longer surprised Jayce Perlas, but it still made him sad. Friends were posting messages about the passing of another friend who was “gone too soon.”

By now, the updates took on a certain template. The deceased was usually male, in his 20s or 30s, openly or secretly gay, his sudden demise simply explained as “hard-core pneumonia” or tuberculosis – infections that could normally be treated by antibiotics.

The virtual but connected universe of Facebook provided a safe haven for final good-byes, an outlet for grief that could not be expressed at hushed and hurried funerals.

At its worst, Perlas, an entrepreneur, has read about three deaths in one week. At the funerals of close friends, he says, there is always a profound grief and sadness, but there is something else, too.

“In every funeral I have attended, the air is thick with the unspoken thought: Could it be one of us next?”

San Francisco in the 80s

The Philippines is one of three countries in the Asia-Pacific Region described as having an “expanding epidemic.” In 2000, one new HIV case every three days was reported. By the end of 2013, that number had increased to one new HIV case every two hours.

To those who witnessed it and still remember, the current situation is reminiscent of San Francisco in the 1980s when mostly gay men got infected and began dying due to what was later identified as AIDS.

HIV activist Tona Benfield, 53, still remembers the early days of AIDS. HIV had yet to be discovered as its cause and men were dying from what was then called the “gay cancer.”

“I lost many friends then. It offends and angers me that I continue to lose friends today,” said Benfield, shaking in outrage.

As a trained HIV counselor at an HIV testing facility subsidized by the Department of Health (DOH), Chris Lagman sees many cases and many stages of HIV. Some come in to get tested for the first time while some who get tested are already showing early signs of opportunistic infections.

Like Perlas, Lagman sees Facebook posts about death of friends and acquaintances. The reasons are cryptic, but from the cases he sees in the clinic, Lagman senses it is most likely a death caused by HIV-related complications – a death that could have been prevented with early diagnosis and treatment.

Early signs

Since 1984, when the Philippines reported its first case of HIV, the island nation of more than 100 million has always been a low-incidence country. Less than 1 percent of its general population is infected with HIV.

Around 2009, things began to change. The main mode of transmission of the virus shifted to men having sex with men (MSM), and new infections among a small group of injecting drug users were reported.

More than 25,000 new HIV infections – around 85 percent of the total 30,356 recorded infections in the country – were reported from 2010-2015. An estimated 81 percent of total HIV infections cluster around MSM, with more than half of the cases belonging to the 25-34 age group.

Data released by the DOH last November showed that HIV infections increased by close to 800 percent in the 15 to 24 age group from 2001 to 2015.

The DOH forecasts that total HIV infections could reach 133,000 by 2022 if the current trend continues.

“To reverse the increase in infections, we need to increase condom use and bring it up to the levels of 80 percent. We need to get people tested and get them on treatment,” said Dr. Genesis Samonte, DOH HIV surveillance head.

Increasing condom use among MSM from its current level of 44 percent will require addressing social, religious and legal obstacles, starting with updating the HIV/AIDS Prevention Law of 1998, which prohibits minors from getting an HIV test without parental consent, hampering early diagnosis and subsequent treatment.

“We need to allow young people to access HIV testing. We need harm reduction programs [for people who inject drugs]. We need to overhaul our legal framework on HIV,” said Jonas Bagas, an HIV activist who has been lobbying for amendments to the HIV law.

“The current law is designed for general population epidemics. Awareness activities are not targeted to inform important sub-populations about prevention and where they could get treatment,” argued Bagas.

The proposed amendments to the HIV law include eliminating the need for parental consent for 15-17-year olds to get an HIV test, strengthening grievance mechanisms for cases of discrimination and allocating more of the budget to information and education drives.

The DOH HIV and AIDS Unit has about 600 million pesos ($13 million) for HIV treatment and prevention from this year’s budget. About 400 million pesos of that will go to providing free antiretroviral (ART) treatment to the more than 12,000 Filipinos who are currently enrolled in the program. The rest will go to purchasing condoms and testing kits, and information materials.

Samonte admits it is not enough and part of the DOH’s interventions will be to find ways to augment this budget.

Stigma and shame

The DOH HIV/AIDS Registry shows 415 AIDS related deaths from January to November 2015. But Samonte recognizes that this number is grossly understated as many deaths are quietly passed off as pneumonia or meningitis. “Some go undiagnosed,” said Samonte.

“The Philippines could look like San Francisco in the 80s, during the height of the AIDS scare. But back then, life-saving ARV treatment was not available. Now, ARV treatment is available and free. No one should have to die from HIV-related infections in 2016.”

“Back then, we called it what it was. ‘He died of AIDS,’ we would say. Here, they say, ‘Oh, it was hard-core pneumonia.'”

But some still do. Kate Leyritana, a doctor at an HIV testing clinic, recalls one incident where she lost one of her patients just a few months after diagnosis. “His mother only knew her son had HIV in his last days. She asked me, ‘Why am I the last to know? I am his mother. I should be the first one he can talk to.’ I had no words.”

The mother still texts Leyritana each December on the anniversary of her son’s 2012 death to say she misses him.